SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Verso Corporation (VRS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 33/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VRS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.72
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.09
Book Value / Share$0.00
Revenue / Share$37.33
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-3.29 |
$1.47B |
$-173.83M |
-11.8% |
| 2013 |
$-2.09 |
$1.39B |
$-111.21M |
-8% |
| 2014 |
$-6.62 |
$1.3B |
$-352.96M |
-27.2% |
| 2015 |
$-5.19 |
$3.12B |
$-422M |
-13.5% |
| 2016 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2017 |
$-0.87 |
$2.46B |
$-30M |
-1.2% |
| 2018 |
$4.87 |
$2.68B |
$171M |
6.4% |
| 2019 |
$2.73 |
$2.44B |
$96M |
3.9% |
| 2020 |
$-2.95 |
$1.36B |
$-101M |
-7.4% |
| 2021 |
$-0.09 |
$1.28B |
$-3M |
-0.2% |
